Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

BACKGROUND AND AIMS: Safety and efficacy of budesonide multimatrix, an oral extended-release second-generation corticosteroid designed for targeted delivery throughout the colon, were examined for induction of remission in patients with mild to moderate ulcerative colitis refractory to baseline mesa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Crohns Colitis
Hlavní autoři: Rubin, David T., Cohen, Russell D., Sandborn, William J., Lichtenstein, Gary R., Axler, Jeffrey, Riddell, Robert H., Zhu, Cindy, Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881669/
https://ncbi.nlm.nih.gov/pubmed/28333362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjx032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky